{
  "DOI": "10.1007/s10689-023-00330-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-023-00330-7",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eRecent genetic sequencing studies in large series’ of predominantly childhood medulloblastoma have implicated loss-of-function, predominantly truncating, variants in the \u003cjats:italic\u003eELP1\u003c/jats:italic\u003e and \u003cjats:italic\u003eGPR161\u003c/jats:italic\u003e genes in causation of the MB\u003cjats:sub\u003eSHH\u003c/jats:sub\u003e subtype specifically. The latter association, along with a report of an index case with some features of Gorlin syndrome has led to speculation that \u003cjats:italic\u003eGPR161\u003c/jats:italic\u003e may also cause Gorlin syndrome. We show that these genes are associated with relatively low absolute risks of medulloblastoma from extrapolating lifetime risks in the general population and odds ratios from the population database gnomAD. The projected risks are around 1 in 270–430 for \u003cjats:italic\u003eELP1\u003c/jats:italic\u003e and 1 in 1600–2500 for \u003cjats:italic\u003eGPR161.\u003c/jats:italic\u003e These risks do not suggest the need for MRI screening in infants with \u003cjats:italic\u003eELP1\u003c/jats:italic\u003e or \u003cjats:italic\u003eGPR161\u003c/jats:italic\u003e variants as this is not currently recommended for \u003cjats:italic\u003ePTCH1\u003c/jats:italic\u003e where the risks are equivalent or higher. We also screened 27 \u003cjats:italic\u003ePTCH1/SUFU\u003c/jats:italic\u003e pathogenic variant-negative patients with Gorlin syndrome for \u003cjats:italic\u003eGPR161\u003c/jats:italic\u003e and found no suspicious variants. Given the population frequencies of 0.0962% for \u003cjats:italic\u003eGPR161\u003c/jats:italic\u003e and 0.0687% for \u003cjats:italic\u003eELP1\u003c/jats:italic\u003e, neither of these genes can be a cause of Gorlin syndrome with an unexplained population frequency far lower at 0.0021%.\u003c/jats:p\u003e",
  "alternative-id": [
    "330"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "22 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "28 February 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "24 March 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical declaration",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Ethical approval for the use of anonymised samples from the Manchester Centre for Genomic Medicine archive was obtained from the North West – Greater Manchester Central Research Ethics Committee (reference 10/H1008/74)."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Smith",
      "given": "Miriam J",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Woodward",
      "given": "Emma R",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-8482-5784",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Evans",
      "given": "D Gareth",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        3,
        24
      ]
    ],
    "date-time": "2023-03-24T09:02:57Z",
    "timestamp": 1679648577000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        6,
        16
      ]
    ],
    "date-time": "2023-06-16T04:26:38Z",
    "timestamp": 1686889598000
  },
  "funder": [
    {
      "award": [
        "IS-BRC-1215-20007"
      ],
      "name": "National Institute of health Research Biomedical Research centre Manchester"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        4
      ]
    ],
    "date-time": "2024-03-04T03:31:23Z",
    "timestamp": 1709523083948
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2023,
        3,
        24
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2023,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            3,
            24
          ]
        ],
        "date-time": "2023-03-24T00:00:00Z",
        "timestamp": 1679616000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            3,
            24
          ]
        ],
        "date-time": "2023-03-24T00:00:00Z",
        "timestamp": 1679616000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00330-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-023-00330-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00330-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "341-344",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2023,
        3,
        24
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        3,
        24
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "330_CR1",
      "unstructured": "https://www.cancerresearchuk.org/about-cancer/childrens-cancer/brain-tumours/types/medulloblastoma"
    },
    {
      "key": "330_CR2",
      "unstructured": "https://www.cancer.net/cancer-types/medulloblastoma-childhood/statistics#:~:text=About%2020%25%20of%20childhood%20brain,ages%20of%205%20and%209"
    },
    {
      "DOI": "10.1007/s10689-021-00247-z",
      "author": "L Guerrini-Rousseau",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "330_CR3",
      "unstructured": "Guerrini-Rousseau L, Smith MJ, Kratz CP et al (2021) Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG). Fam Cancer 20(4):317–325. https://doi.org/10.1007/s10689-021-00247-z",
      "volume": "20",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41586-020-2164-5",
      "author": "SM Waszak",
      "doi-asserted-by": "publisher",
      "first-page": "396",
      "issue": "7803",
      "journal-title": "Nature",
      "key": "330_CR4",
      "unstructured": "Waszak SM, Robinson GW, Gudenas BL et al (2020) Germline elongator mutations in Sonic hedgehog medulloblastoma. Nature 580(7803):396–401. https://doi.org/10.1038/s41586-020-2164-5",
      "volume": "580",
      "year": "2020"
    },
    {
      "DOI": "10.1200/JCO.19.00577",
      "author": "M Begemann",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "issue": "1",
      "journal-title": "J Clin Oncol",
      "key": "330_CR5",
      "unstructured": "Begemann M, Waszak SM, Robinson GW et al (2020) Germline GPR161 mutations predispose to Pediatric Medulloblastoma. J Clin Oncol 38(1):43–50. https://doi.org/10.1200/JCO.19.00577Epub 2019 Oct 14",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-0595",
      "author": "WD Foulkes",
      "doi-asserted-by": "publisher",
      "first-page": "e62",
      "issue": "12",
      "journal-title": "Clin Cancer Res",
      "key": "330_CR6",
      "unstructured": "Foulkes WD, Kamihara J, Evans DGR et al (2017) Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome. Clin Cancer Res 23(12):e62–e67. https://doi.org/10.1158/1078-0432.CCR-17-0595",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1002/ajmg.a.33139",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "327",
      "issue": "2",
      "journal-title": "Am J Med Genet A",
      "key": "330_CR7",
      "unstructured": "Evans DG, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A(2):327–332. https://doi.org/10.1002/ajmg.a.33139",
      "volume": "152A",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-021-00269-7",
      "author": "MJ Smith",
      "doi-asserted-by": "publisher",
      "first-page": "343",
      "issue": "3",
      "journal-title": "Fam Cancer",
      "key": "330_CR8",
      "unstructured": "Smith MJ, Evans DG (2022) PTCH2 is not a strong candidate gene for gorlin syndrome predisposition. Fam Cancer 21(3):343–346. https://doi.org/10.1007/s10689-021-00269-7",
      "volume": "21",
      "year": "2022"
    },
    {
      "DOI": "10.1210/jc.2014-1984",
      "author": "E Karaca",
      "doi-asserted-by": "publisher",
      "first-page": "E140",
      "issue": "1",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "330_CR9",
      "unstructured": "Karaca E, Buyukkaya R, Pehlivan D et al (2015) Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome. J Clin Endocrinol Metab 100(1):E140–E147. https://doi.org/10.1210/jc.2014-1984",
      "volume": "100",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0053579",
      "doi-asserted-by": "crossref",
      "key": "330_CR10",
      "unstructured": "Guo Q, Yang Y, Mu Y et al (2013) : Pituitary stalk interruption syndrome in Chinese people: clinical characteristic analysis of 55 cases. PLoS One. 8: e53579-10.1371/journal.pone.0053579"
    }
  ],
  "reference-count": 10,
  "references-count": 10,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.21203/rs.3.rs-2300635/v1",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-023-00330-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Perspectives on the implications of carrying putative pathogenic variants in the medulloblastoma predisposition genes ELP1 and GPR161"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "22"
}